Can changing the prodrug moiety in remdesivir be a life-saving strategy in COVID-19 infection?

被引：0
作者：
Prabha, Praisy K. [1 ]
Prakash, Ajay [2 ]
Medhi, Bikash [2 ]
机构：
[1] Postgrad Inst Med Educ & Res, Dept Neurol, Chandigarh 160012, India
[2] Postgrad Inst Med Educ & Res, Dept Pharmacol, Chandigarh 160012, India
来源：
INDIAN JOURNAL OF MEDICAL RESEARCH | 2023年 / 157卷 / 01期
基金：
英国科研创新办公室;
关键词：
DISCOVERY; GS-5734; VIRUS;
D O I：
10.4103/ijmr.ijmr_233_22
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
[No abstract available]
引用
收藏
页码：100 / 103
页数：4
相关论文
共 25 条
  • [1] Remdesivir for the treatment of COVID-19
    Ansems, Kelly
    Grundeis, Felicitas
    Dahms, Karolina
    Mikolajewska, Agata
    Thieme, Volker
    Piechotta, Vanessa
    Metzendorf, Maria-Inti
    Stegemann, Miriam
    Benstoem, Carina
    Fichtner, Falk
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2021, (08):
  • [2] Beigel JH, 2020, NEW ENGL J MED, V383, P1813, DOI [10.1056/NEJMoa2007764, 10.1056/NEJMc2022236]
  • [3] Broad spectrum antiviral remdesivir inhibits human endemic and zoonotic deltacoronaviruses with a highly divergent RNA dependent RNA polymerase
    Brown, Ariane J.
    Won, John J.
    Graham, Rachel L.
    Dinnon, Kenneth H., III
    Sims, Amy C.
    Feng, Joy Y.
    Cihlar, Tomas
    Denison, Mark R.
    Baric, Ralph S.
    Sheahan, Timothy P.
    [J]. ANTIVIRAL RESEARCH, 2019, 169
  • [4] Benefit-risk assessment for brincidofovir for the treatment of smallpox: US Food and Drug Administration's Evaluation
    Chan-Tack, Kirk
    Harrington, Patrick
    Bensman, Timothy
    Choi, Su-Young
    Donaldson, Eric
    O'Rear, Julian
    McMillan, David
    Myers, Laine
    Seaton, Mark
    Ghantous, Hanan
    Cao, Yu
    Valappil, Thamban
    Birnkrant, Debra
    Struble, Kimberly
    [J]. ANTIVIRAL RESEARCH, 2021, 195
  • [5] ClinicalTrials.gov. US National Library of Medicine. National Institute of Health, SINGL DOS STUD EV PK
  • [6] Remdesivir: A Review of Its Discovery and Development Leading to Emergency Use Authorization for Treatment of COVID-19
    Eastman, Richard T.
    Roth, Jacob S.
    Brimacombe, Kyle R.
    Simeonov, Anton
    Shen, Min
    Patnaik, Samarjit
    Hall, Matthew D.
    [J]. ACS CENTRAL SCIENCE, 2020, 6 (05) : 672 - 683
  • [7] European Medicines Agency, 2020, Summary on compassionate use
  • [8] Ether lipid-ester prodrugs of acyclic nucleoside phosphonates: Activity against adenovirus replication in vitro
    Hartline, CB
    Gustin, KM
    Wan, WB
    Ciesla, SL
    Beadle, JR
    Hostetler, KY
    Kern, ER
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2005, 191 (03) : 396 - 399
  • [9] Oral 1-O-octadecyl-2-O-benzyl-sn-glycero-3-cidofovir targets the lung and is effective against a lethal respiratory challenge with ectromelia virus in mice
    Hostetler, Karl Y.
    Beadle, James R.
    Trahan, Julissa
    Aldern, Kathy A.
    Owens, Gelita
    Schriewer, Jill
    Melman, Lora
    Buller, R. Mark
    [J]. ANTIVIRAL RESEARCH, 2007, 73 (03) : 212 - 218
  • [10] Emergency Use Authorization of Remdesivir The Need for a Transparent Distribution Process
    Ison, Michael G.
    Wolfe, Cameron
    Boucher, Helen W.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2020, 323 (23): : 2365 - 2366
123